BATTAGLIA, GLORIANA
 Distribuzione geografica
Continente #
NA - Nord America 3.472
AS - Asia 2.823
EU - Europa 1.216
SA - Sud America 452
AF - Africa 141
Continente sconosciuto - Info sul continente non disponibili 78
OC - Oceania 3
Totale 8.185
Nazione #
US - Stati Uniti d'America 3.369
SG - Singapore 1.041
CN - Cina 824
BR - Brasile 364
SE - Svezia 335
IE - Irlanda 324
VN - Vietnam 323
HK - Hong Kong 198
TR - Turchia 165
IT - Italia 101
FR - Francia 98
BD - Bangladesh 87
ZA - Sudafrica 83
NL - Olanda 77
DE - Germania 58
CA - Canada 55
FI - Finlandia 43
RU - Federazione Russa 40
GB - Regno Unito 37
IN - India 36
AR - Argentina 31
CI - Costa d'Avorio 30
UA - Ucraina 24
MX - Messico 22
AT - Austria 20
IQ - Iraq 16
JP - Giappone 15
CO - Colombia 14
TH - Thailandia 14
EC - Ecuador 11
ES - Italia 11
PL - Polonia 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
JO - Giordania 9
MA - Marocco 9
PH - Filippine 9
PK - Pakistan 9
CL - Cile 8
KR - Corea 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
ID - Indonesia 6
BO - Bolivia 5
PA - Panama 5
BG - Bulgaria 4
HR - Croazia 4
IL - Israele 4
IR - Iran 4
JM - Giamaica 4
LY - Libia 4
OM - Oman 4
PE - Perù 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AL - Albania 3
AU - Australia 3
KE - Kenya 3
MY - Malesia 3
NI - Nicaragua 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
BY - Bielorussia 2
CR - Costa Rica 2
EG - Egitto 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 8.102
Città #
Chandler 524
Singapore 494
Ashburn 405
Santa Clara 354
Dublin 324
San Jose 290
Hong Kong 186
Beijing 164
Dallas 146
Dearborn 130
Izmir 127
Nanjing 111
Ho Chi Minh City 105
New York 98
Boardman 94
Council Bluffs 90
Johannesburg 79
Hanoi 78
Los Angeles 76
Princeton 70
Lauterbourg 57
Shanghai 50
Wilmington 42
Columbus 41
Moscow 35
Helsinki 34
Buffalo 30
Hebei 30
São Paulo 30
Nanchang 29
Abidjan 27
Shenyang 27
Kocaeli 26
Toronto 24
Milan 22
Munich 21
Changsha 20
The Dalles 20
Guangzhou 19
Hangzhou 19
Kunming 19
Seattle 19
Tianjin 18
Vienna 18
Jiaxing 17
Frankfurt am Main 16
Haiphong 16
Rome 15
Hefei 14
Belo Horizonte 13
Jinan 13
Jacksonville 12
Montreal 12
Rio de Janeiro 12
San Mateo 12
Tokyo 12
Zhengzhou 12
London 11
Chicago 10
Da Nang 10
Fremont 10
Norwalk 10
Brussels 9
Orem 9
San Francisco 9
Turku 9
Atlanta 8
Porto Alegre 8
Stockholm 8
Amman 7
Baghdad 7
Campinas 7
Houston 7
Hải Dương 7
Warsaw 7
Ann Arbor 6
Bangkok 6
Boston 6
Brooklyn 6
Chennai 6
Curitiba 6
Denver 6
Naples 6
Poplar 6
Tashkent 6
Brasília 5
Dhaka 5
Nuremberg 5
Panama City 5
Salvador 5
Wuhan 5
Borås 4
Bình Phước 4
Cambridge 4
Can Tho 4
Caxias do Sul 4
Dubai 4
Guayaquil 4
Lanzhou 4
Leawood 4
Totale 5.077
Nome #
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis] 210
H2-blockers in the treatment of ulcer disease in the elderly 187
Long-term treatment for gastric and duodenal ulcer 176
Individualized treatment of duodenal ulcer disease. A pilot study 172
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 164
[Clinical usefulness of the blood gastrin curve after protein meal in duodenal ulcer] 161
Clinical markers of slow healing and relapsing gastric ulcer 158
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 156
Cimetidine, ranitidine, and pirenzepine in the treatment of duodenal ulcer: A six-month low-dose treatment period followed by a six-month observation period 153
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 151
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 151
Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study 150
800 mg of cimetidine versus 300 mg of ranitidine at bedtime in the short-term treatment of duodenal ulcer: A cost/benefit study 150
TERAPIA DI MANTENIMENTO PER UN ANNO CON ANTI-H2 NELL'ULCERA PEPTICA DELL'ANZIANO: IMPORTANZA DELLA SINTOMATOLOGIA COME MARKER DI RECIDIVA 147
Gastric and duodenal ulcer in the same patient 145
Azithromycin for the cure of Helicobacter pylori infection 143
CARATTERISTICHE EPIDEMIOLOGICHE, CLINICHE E FUNZIONALI IN PAZIENTI CON SANGUINAMENTO DA ULCERA DUODENALE 140
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 140
Compliance with therapy for ulcer disease: clinical experience and review of the literature 138
Cefixime for the eradication of helicobacter pylori 135
Mucosal pepsin and group I pepsinogen concentration in peptic ulcer patients with a history of bleeding 132
A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study 131
Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs 129
Early drop in anti Helicobacter pylori IgG titre after eradication therapy with clarithromycin 129
Clarithromycin for the cure of Helicobacter pylori infection: One or two weeks of treatment 126
A preliminary report on Helicobacter pylori and antral gastrin concentration in patients with duodenal ulcer 125
Gastric ulcer and stomach aging: Pathophysiology and clinical implications 124
LA BULBODUODENITE NON ULCEROSA: ASPETTI CLINICI E TRATTAMENTO FARMACOLOGICO 122
A therapeutic strategy after a first ineffective cure of H. pylori infection. One-centre experience on 74 consecutive patients 121
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 121
Milk consumption and duodenal ulcer outcome: A short- and long-term study 120
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 120
Blood pepsinogen as a subclinical marker for duodenal ulcer 119
Fasting and post-prandial serum gastrin concentrations in peptic ulcer disease. Pathophysiological considerations in relationship to the different localization 119
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 119
H2antagonists and gastric ulcer: A multicenter, randomized, double-blind, controlled study comparing nizatidine with ranitidine 118
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 118
ACIDO N-ACETILNEURAMINICO DOPO PENTAGASTRINA E SECRETINA IN SOGGETTI CON ULCERA DUODENALE E DISPEPSIA NON ULCEROSA 114
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? 110
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 109
Risk factors of duodenal ulcer bleeding: the role of smoking and nicotine 108
Gastric bicarbonate secretion in high-relapsing, smoking duodenal ulcer patients 108
ULCERA PEPTICA E CIRROSI EPATICA. CONSIDERAZIONI CLINICO-EPIDEMIOLOGISCHE 108
Hemorrhagic duodenal ulcer disease: Clinical and biochemical findings in a case-control pilot study 106
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study 105
Helicobacter pylori infection, cigarette smoking and alcohol consumption. A histological and clinical study on 286 subjects 103
Studio scintigrafico del tempo di svuotamento gastrico in pazienti con ulcera duodenale 102
EFFETTO DELLA NIZATIDINA E DEL MISOPROSTOL SULL'ATTIVITA PEPTICA E SUL MUCO GASTRICO SOLUTO 100
The natural history of duodenal ulcer disease 99
Ulcera gastrica, ulcera duodenale e gruppi sanguigni "maggiori e minori". Aspetti epidemiologici, correlazioni funzionali, implicazioni cliniche 98
Personality traits and gastric acid secretion in ulcer disease 95
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study 91
Serum pepsinogen A and C levels: A follow-up study on 476 patients after Helicobacter pylori eradication 88
Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series 88
Sucralfate gel versus ranitidine in the treatment of gastroesophageal reflux disease: A controlled study 88
Ranitidine bismuthate citrate as a second step for the eradication of Helicobacter pylori 87
Sucralfate and cisapride in the treatment of duodenogastric reflux and dyspepsia: A randomized study 87
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study 84
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 84
Helicobacter pylori eradication: Can a successful therapy be predicted? 84
Sucralfate for preventing gastric ulcer relapse: A controlled prospective study 84
Lymphoid follicles in gastric mucosa of Helicobacter pylori infected patients regress after eradication treatment 82
Valutazione clinica della gastrinemia basale nella malattia ulcerosa 79
High IgE serum levels and "peptic" ulcers: clinical and functional approach 76
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules 75
Early fall of anti Helicobacter pylori IgG in eradicated patients with non-ulcer dyspepsia 75
One year follow-up of malt lymphoma of the stomach: Evidence for the need of an accurate diagnostic management 69
Helicobacter pylori and Serum Pepsinogen A, Pepsinogen C, and Gastrin: A Methodological Note 65
Seasonal Fluctuations in Peptic Ulcer Bleeding: An Italian Experience 60
LA TERAPIA DELLA MALATTIA ULCEROSA NELL'ANZIANO: STUDIO PROSPETTICO RANDOMIZZATO CON FARMACI ANTISECRETORI 54
Totale 8.185
Categoria #
all - tutte 28.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022269 0 0 1 17 14 2 3 25 18 15 28 146
2022/20231.461 133 149 131 132 95 184 7 122 415 6 71 16
2023/2024402 13 49 11 9 31 127 7 34 17 34 33 37
2024/20251.742 36 78 90 100 284 284 92 71 200 115 112 280
2025/20263.045 303 250 333 222 456 216 287 88 389 242 148 111
2026/2027278 115 160 3 0 0 0 0 0 0 0 0 0
Totale 8.185